Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

1.

Polymorphism in LEP and LEPR May Modify Leptin Levels and Represent Risk Factors for Thyroid Cancer.

Marcello MA, Calixto AR, de Almeida JF, Martins MB, Cunha LL, Cavalari CA, Etchebehere EC, da Assumpção LV, Geloneze B, Carvalho AL, Ward LS.

Int J Endocrinol. 2015;2015:173218. doi: 10.1155/2015/173218. Epub 2015 Feb 25.

2.

Polymorphisms of cell cycle control genes influence the development of sporadic medullary thyroid carcinoma.

Barbieri RB, Bufalo NE, Secolin R, Assumpção LV, Maciel RM, Cerutti JM, Ward LS.

Eur J Endocrinol. 2014 Dec;171(6):761-7. doi: 10.1530/EJE-14-0461.

PMID:
25565272
3.

TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves' disease and Graves' ophthalmopathy.

Bufalo NE, Dos Santos RB, Marcello MA, Piai RP, Secolin R, Romaldini JH, Ward LS.

J Endocrinol Invest. 2014 Dec 28. [Epub ahead of print]

PMID:
25543543
4.

Immune response in thyroid cancer: widening the boundaries.

Ward LS.

Scientifica (Cairo). 2014;2014:125450. doi: 10.1155/2014/125450. Epub 2014 Sep 25. Review.

5.

Thyroid tumors: are we unveiling the puzzle?

Ward LS.

Endocr Relat Cancer. 2014 Oct;21(5):E7-8. doi: 10.1530/ERC-14-0407. No abstract available.

PMID:
25245018
6.

CD8+ tumour-infiltrating lymphocytes and COX2 expression may predict relapse in differentiated thyroid cancer.

Cunha LL, Marcello MA, Nonogaki S, Morari EC, Soares FA, Vassallo J, Ward LS.

Clin Endocrinol (Oxf). 2014 Aug 16. doi: 10.1111/cen.12586. [Epub ahead of print]

PMID:
25130519
7.

The influence of the environment on the development of thyroid tumors: a new appraisal.

Marcello MA, Malandrino P, Almeida JF, Martins MB, Cunha LL, Bufalo NE, Pellegriti G, Ward LS.

Endocr Relat Cancer. 2014 Oct;21(5):T235-54. doi: 10.1530/ERC-14-0131. Epub 2014 Jun 19. Review.

8.

A putative OTU domain-containing protein 1 deubiquitinating enzyme is differentially expressed in thyroid cancer and identifies less-aggressive tumours.

Carneiro AP, Reis CF, Morari EC, Maia YC, Nascimento R, Bonatto JM, de Souza MA, Goulart LR, Ward LS.

Br J Cancer. 2014 Jul 29;111(3):551-8. doi: 10.1038/bjc.2014.331. Epub 2014 Jun 17.

PMID:
24937664
9.

Is thyroid stunning clinically relevant? A retrospective analysis of 208 patients.

Etchebehere EC, Santos AO, Matos PS, Assumpção LV, Lima MC, Lima MC, Ward LS.

Arq Bras Endocrinol Metabol. 2014 Apr;58(3):292-300.

10.

Obesity and thyroid cancer.

Marcello MA, Cunha LL, Batista FA, Ward LS.

Endocr Relat Cancer. 2014 Oct;21(5):T255-71. doi: 10.1530/ERC-14-0070. Epub 2014 Apr 16. Review.

11.

Both gender and concurrent chronic lymphocytic thyroiditis may influence the nuclear texture of papillary thyroid carcinomas cells.

Cunha LL, Ferreira Rde C, de Matos PS, da Assumpção LV, Ward LS.

Endocr Res. 2014;39(3):126-9. doi: 10.3109/07435800.2013.864302. Epub 2014 Jan 24.

PMID:
24460065
12.

CD8+ TIL Recruitment May Revert the Association of MAGE A3 with Aggressive Features in Thyroid Tumors.

Martins MB, Marcello MA, Batista Fde A, Cunha LL, Morari EC, Soares FA, Vassallo J, Ward LS.

J Immunol Res. 2014;2014:921864. doi: 10.1155/2014/921864. Epub 2014 Nov 4.

13.

The role of the inflammatory microenvironment in thyroid carcinogenesis.

Cunha LL, Marcello MA, Ward LS.

Endocr Relat Cancer. 2014 Apr 28;21(3):R85-R103. doi: 10.1530/ERC-13-0431. Print 2014 Jun. Review.

14.

P53 and expression of immunological markers may identify early stage thyroid tumors.

Marcello MA, Morari EC, Cunha LL, De Nadai Silva AC, Carraro DM, Carvalho AL, Soares FA, Vassallo J, Ward LS.

Clin Dev Immunol. 2013;2013:846584. doi: 10.1155/2013/846584. Epub 2013 Sep 19.

15.

Thyroid nodules and differentiated thyroid cancer: update on the Brazilian consensus.

Rosário PW, Ward LS, Carvalho GA, Graf H, Maciel RM, Maciel LM, Maia AL, Vaisman M; Sociedade Brasileira de Endocrinologia e Metabologia.

Arq Bras Endocrinol Metabol. 2013 Jun;57(4):240-64. English, Portuguese.

16.

Comparative analysis of the new guidelines and consensuses for the management of hypothyroidism, thyroid nodules, and differentiated thyroid cancer.

Paz-Filho G, Graf H, Ward LS.

Arq Bras Endocrinol Metabol. 2013 Jun;57(4):233-9. English, Portuguese. No abstract available.

17.

The Brazilian consensus for the diagnosis and treatment of hyperthyroidism: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism.

Maia AL, Scheffel RS, Meyer EL, Mazeto GM, Carvalho GA, Graf H, Vaisman M, Maciel LM, Ramos HE, Tincani AJ, Andrada NC, Ward LS; Brazilian Society of Endocrinology and Metabolism.

Arq Bras Endocrinol Metabol. 2013 Apr;57(3):205-32. English, Portuguese.

18.

The clinical use of thyroid function tests.

Carvalho GA, Perez CL, Ward LS.

Arq Bras Endocrinol Metabol. 2013 Apr;57(3):193-204. English, Portuguese.

19.

The Brazilian consensus for the clinical approach and treatment of subclinical hypothyroidism in adults: recommendations of the thyroid Department of the Brazilian Society of Endocrinology and Metabolism.

Sgarbi JA, Teixeira PF, Maciel LM, Mazeto GM, Vaisman M, Montenegro Junior RM, Ward LS; Brazilian Society of Endocrinology and Metabolism.

Arq Bras Endocrinol Metabol. 2013 Apr;57(3):166-83. English, Portuguese.

20.

Thyroid consensuses: guidelines for clinical practice.

Ward LS, Maciel LM.

Arq Bras Endocrinol Metabol. 2013 Apr;57(3):161-2. English, Portuguese. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk